These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 29348866)

  • 1. Protein methyltransferases and demethylases dictate CD8+ T-cell exclusion in squamous cell carcinoma of the head and neck.
    Vougiouklakis T; Bao R; Nakamura Y; Saloura V
    Oncotarget; 2017 Dec; 8(68):112797-112808. PubMed ID: 29348866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune profiles in primary squamous cell carcinoma of the head and neck.
    Saloura V; Izumchenko E; Zuo Z; Bao R; Korzinkin M; Ozerov I; Zhavoronkov A; Sidransky D; Bedi A; Hoque MO; Koeppen H; Keck MK; Khattri A; London N; Kotlov N; Fatima A; Vougiouklakis T; Nakamura Y; Lingen M; Agrawal N; Savage PA; Kron S; Kline J; Kowanetz M; Seiwert TY
    Oral Oncol; 2019 Sep; 96():77-88. PubMed ID: 31422218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor activity of human papillomavirus type 16 E7-specific T cells against virally infected squamous cell carcinoma of the head and neck.
    Albers A; Abe K; Hunt J; Wang J; Lopez-Albaitero A; Schaefer C; Gooding W; Whiteside TL; Ferrone S; DeLeo A; Ferris RL
    Cancer Res; 2005 Dec; 65(23):11146-55. PubMed ID: 16322265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the T-Cell Receptor Repertoire and Immune Microenvironment in Patients with Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck.
    Saloura V; Fatima A; Zewde M; Kiyotani K; Brisson R; Park JH; Ikeda Y; Vougiouklakis T; Bao R; Khattri A; Seiwert T; Cipriani N; Lingen M; Vokes E; Nakamura Y
    Clin Cancer Res; 2017 Aug; 23(16):4897-4907. PubMed ID: 28442504
    [No Abstract]   [Full Text] [Related]  

  • 5. MicroRNA-363 targets myosin 1B to reduce cellular migration in head and neck cancer.
    Chapman BV; Wald AI; Akhtar P; Munko AC; Xu J; Gibson SP; Grandis JR; Ferris RL; Khan SA
    BMC Cancer; 2015 Nov; 15():861. PubMed ID: 26545583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of human aldehyde dehydrogenase 1 family member A1 as a novel CD8+ T-cell-defined tumor antigen in squamous cell carcinoma of the head and neck.
    Visus C; Ito D; Amoscato A; Maciejewska-Franczak M; Abdelsalem A; Dhir R; Shin DM; Donnenberg VS; Whiteside TL; DeLeo AB
    Cancer Res; 2007 Nov; 67(21):10538-45. PubMed ID: 17974998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of human papillomavirus-16 infection on CD8+ T-cell recognition of a wild-type sequence p53264-272 peptide in patients with squamous cell carcinoma of the head and neck.
    Sirianni N; Ha PK; Oelke M; Califano J; Gooding W; Westra W; Whiteside TL; Koch WM; Schneck JP; DeLeo A; Ferris RL
    Clin Cancer Res; 2004 Oct; 10(20):6929-37. PubMed ID: 15501971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human leukocyte antigen (HLA) class I defects in head and neck cancer: molecular mechanisms and clinical significance.
    Ferris RL; Hunt JL; Ferrone S
    Immunol Res; 2005; 33(2):113-33. PubMed ID: 16234579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human cytotoxic T-cell lines with restricted specificity for squamous cell carcinoma of the head and neck.
    Yasumura S; Hirabayashi H; Schwartz DR; Toso JF; Johnson JT; Herberman RB; Whiteside TL
    Cancer Res; 1993 Mar; 53(6):1461-8. PubMed ID: 8443824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enrichment in tumor-reactive CD8+ T-lymphocytes by positive selection from the blood and lymph nodes of patients with head and neck cancer.
    Letessier EM; Heo DS; Okarma T; Johnson JT; Herberman RB; Whiteside TL
    Cancer Res; 1991 Aug; 51(15):3891-9. PubMed ID: 1677310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Matrisomal Gene Panel and Its Association with Immune Cell Infiltration in Head and Neck Carcinomas.
    Belotti Y; Lim SB; Iyer NG; Lim WT; Lim CT
    Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of pro- and antiapoptotic proteins in circulating CD8+ T cells of patients with squamous cell carcinoma of the head and neck.
    Kim JW; Tsukishiro T; Johnson JT; Whiteside TL
    Clin Cancer Res; 2004 Aug; 10(15):5101-10. PubMed ID: 15297413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of differentially expressed genes in HPV-positive and HPV-negative oropharyngeal squamous cell carcinomas.
    Martinez I; Wang J; Hobson KF; Ferris RL; Khan SA
    Eur J Cancer; 2007 Jan; 43(2):415-32. PubMed ID: 17079134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological characterization of missense mutations occurring within cytotoxic T cell-defined p53 epitopes in HLA-A*0201+ squamous cell carcinomas of the head and neck.
    Ito D; Visus C; Hoffmann TK; Balz V; Bier H; Appella E; Whiteside TL; Ferris RL; DeLeo AB
    Int J Cancer; 2007 Jun; 120(12):2618-24. PubMed ID: 17294448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequencies of tetramer+ T cells specific for the wild-type sequence p53(264-272) peptide in the circulation of patients with head and neck cancer.
    Hoffmann TK; Donnenberg AD; Finkelstein SD; Donnenberg VS; Friebe-Hoffmann U; Myers EN; Appella E; DeLeo AB; Whiteside TL
    Cancer Res; 2002 Jun; 62(12):3521-9. PubMed ID: 12067999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in the T-cell receptor variable beta gene-restricted profile of CD8+ T lymphocytes in the peripheral circulation of patients with squamous cell carcinoma of the head and neck.
    Albers AE; Visus C; Tsukishiro T; Ferris RL; Gooding W; Whiteside TL; De Leo AB
    Clin Cancer Res; 2006 Apr; 12(8):2394-403. PubMed ID: 16638844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gamma-delta T-cells in patients with squamous cell carcinoma of the head and neck.
    Bas M; Bier H; Schirlau K; Friebe-Hoffmann U; Scheckenbach K; Balz V; Whiteside TL; Hoffmann TK
    Oral Oncol; 2006 Aug; 42(7):691-7. PubMed ID: 16527515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of epidermal growth factor receptor gene expression and function decreases proliferation of head and neck squamous carcinoma but not normal mucosal epithelial cells.
    Rubin Grandis J; Chakraborty A; Melhem MF; Zeng Q; Tweardy DJ
    Oncogene; 1997 Jul; 15(4):409-16. PubMed ID: 9242377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autocrine and paracrine chemokine receptor 7 activation in head and neck cancer: implications for therapy.
    Wang J; Seethala RR; Zhang Q; Gooding W; van Waes C; Hasegawa H; Ferris RL
    J Natl Cancer Inst; 2008 Apr; 100(7):502-12. PubMed ID: 18364504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationships between regulatory T cells and CD8+ effector populations in patients with squamous cell carcinoma of the head and neck.
    Chikamatsu K; Sakakura K; Whiteside TL; Furuya N
    Head Neck; 2007 Feb; 29(2):120-7. PubMed ID: 17103408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.